Avenue Therapeutics(DE:49Y)
€0.400.00 (0.00%)
DE:49Y
Avenue Therapeutics earnings date
€0.40
At close:0.00 (0.00%)
Avenue Therapeutics (49Y) Q2 2019 Earnings Report
1 Followers
DE:49Y Q2 2019 EPS Results
- Actual EPS
- -EUR 5.67
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 5.93
DE:49Y Q2 2019 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2019
- Date
- 08/14/2019
- Time
- Before Open
- Conference Call
- Wednesday, August 14, 2019
Q2 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:49Y Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2025 | 2025 (Q3) | ―-0.19 | -1.69 | 88.85% (+1.50) | |
| Aug 18, 2025 | 2025 (Q2) | ―0.09 | -5.65 | 101.63% (+5.75) | |
| May 19, 2025 | 2025 (Q1) | ―-0.55 | -13.54 | 95.95% (+12.99) | |
| Mar 25, 2025 | 2024 (Q4) | -0.50-0.64 | 56.05 | -101.15% (-56.70) | |
| Nov 14, 2024 | 2024 (Q3) | -0.83-1.69 | 3.96 | -142.67% (-5.64) | |
| Aug 09, 2024 | 2024 (Q2) | -0.92-5.65 | -34.29 | 83.51% (+28.64) | |
| May 15, 2024 | 2024 (Q1) | -7.91-13.54 | -90.34 | 85.01% (+76.80) | |
| Mar 18, 2024 | 2023 (Q4) | -6.5956.05 | 8.57 | 553.85% (+47.48) | |
| Nov 13, 2023 | 2023 (Q3) | -17.153.96 | -29.67 | 113.33% (+33.63) | |
| Aug 10, 2023 | 2023 (Q2) | -19.12-34.29 | -27.26 | -25.79% (-7.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

